INTELLECTUAL PROPERTY PURCHASE AGREEMENT

EX-10.1 2 axth_ex10z1.htm CERTIFICATION Certification

Exhibit 10.1

 

INTELLECTUAL PROPERTY PURCHASE AGREEMENT

 

This Intellectual Property Purchase Agreement, hereinafter referred to as the "Agreement", is made and executed on the following terms and conditions among:

 

FracFlow Biotechnologies LP, a Canadian Limited Partnership, whose corporate office is located at 100 Midland Drive, Dieppe, New Brunswick, hereinafter referred to as "FracFlow".

 

American Xanthan Corporation, a Wyoming Corporation, whose corporate office is located 1749 Cheyenne, Wyoming, USA  hereinafter referred to as "Company".

 

"FracFlow and "Company" are sometimes hereinafter collectively referred to as the "Parties", and individually as a "Party".

 

Recitals

 

"FracFlow" legal owner of certain Intellectual Properties including pending patents for the synthesis of Xanthan from Potato Pulp, hereinafter referred to as "Intellectual Property/Properties". (Exhibit A)

 

"Company", established in 2013, is an company focused on intellectual property research and development. "Company" operations include the acquisition, development, marketing and licensing of intellectual properties. Looking to the future, "Company" is seeking entry into the Xanthan manufacturing industry.

 

Whereas, the "Parties" are desirous of entering into this "Agreement", wherein "Company" will purchase the Intellectual Property/Properties of "FracFlow".

 

Now Therefore, the "Parties" hereby agree as follows:

 

Offer and Acceptance

 

The "Parties" specifically offer, accept and agree to all of the terms, conditions, and provisions of this "Agreement".

 

Consideration

 

The consideration of the stock conveyance, acts, mutual promises, covenants and conditions contained herein, and in further consideration of the mutual performance thereof, together with other good and valuable consideration, the receipt thereof, is agreed upon by the "Parties" as legal, adequate, and sufficient.

 

 

 


The "Agreement"

 

1. Parties : The "Parties" to this "Agreement" are: FracFlow Biotechnologies LP and American Xanthan Corporation.

 

2. Sale of Intellectual Property/Properties & Prototype : "Company" agrees to purchase all the rights title and interest of the "Intellectual Property/Properties" of "FracFlow" for 500,000 shares of "Company" restricted common stock at the deemed price of $5.00 a share.

 

3. Non Compete Provision : The undersigned "FracFlow" and each of its signing Members agree not to compete with "Company", or commence, either as an individual or through a new entity, any operation that would be in direct competition with "Company" in the United States and the licensed  "Intellectual Properties" for a period of five (5) years from the date of execution of this "Agreement".

 

4. Acts, Procedures, and Duties of "Company":

 

4.01 Conduct and perform the terms and conditions as set-forth in this "Agreement" with the utmost professionalism, honesty, and forthrightness as is mandated by industry standards pertaining to this undertaking.

 

4.02 Continually oversee, maintain protect, preserve and safeguard the "FracFlow" "Intellectual Properties".

 

4.03 Be responsible for complying with all laws, in particular with those laws applicable to the activities described under this "Agreement".

 

4.04 Use its best efforts to effectuate and comply with all of the terms and conditions of this "Agreement", and with all laws of the respective countries involved.

 

5. Time of Essence: The "Parties" agree that time is of the essence in executing this "Agreement"

 

6. Waiver. No delay or omission on the part of "Parties" in exercising any right hereunder shall operate as a waiver of such right or any other right. A waiver by the "Parties" of a provision of this "Agreement" shall not prejudice or constitute a waiver of the "Party's" right otherwise to demand strict compliance with that provision or any other provision of this "Agreement".

 

7. Execution Venue and Choice of Law. This "Agreement" is executed and entered into and governed by the laws of the State of Wyoming as to any dispute or unresolved issue.

 

8. Severability. If a court of competent jurisdiction finds any provision of this "Agreement" to be invalid or unenforceable as to any circumstance, such finding shall not render that provision invalid or unenforceable as to any other circumstances. If feasible, any such offending provision shall be deemed modified to be within the limits of enforceability or validity; however, if the


offending provision cannot be so modified, it shall be stricken and all other provisions of this Agreement in all other respects shall remain valid and enforceable.

 

9. Commissions and Fees. The "Parties" represent and acknowledge that there are no fees or commissions to be paid to any person or entity resulting from the execution and entry of the "Parties" into this" Agreement".

 

10. Taxes. The "Parties" agree that each "Party" shall be individually and respectively responsible for any and all taxes from Federal, State or local that otherwise that might be owed accessed to a "Party", and each "Party" agrees to hold the other "Parties" harmless from any collection process of any said tax.

 

11. Litigation. Each "Party" states that there are no lawsuits, proceedings, or governmental investigations pending or threatened against them.

 

12. Agreement Not Unconscionable. It is agreed by "Parties" that the terms and conditions of the "Agreement" are not unconscionable to any "Party".

 

13. Entire Agreement. This instrument embodies the whole agreement of the "Parties". There are no promises, terms, conditions, or obligations other than those contained herein. This "Agreement" supersedes all previous communications, representations, or agreements, either verbal or written between the "Parties" hereto. Any agreement entered into between "Parties" after the date of this "Agreement", must be in writing, signed by the "Parties" hereto, and added to this "Agreement" as an addendum.

 

14. Authority and Binding Effect. The execution, delivery, and performance of this "Agreement" by the "Parties" have been duly authorized by all necessary action of the respective entities/companies all are enforceable in accordance with their terms. Such execution, delivery, and performance do not require the consent or approval of any other person or governmental agency or authority. Each signing Party has the capacity and authority to execute this "Agreement". This "Agreement" is binding upon the "Parties" hereto, and is legally enforceable in accordance with the respective terms hereof.

 

IN WITNESS WHEREOF, the "Parties" have caused this "Agreement" to be duly authorized and executed on the day, month and year hereinafter set-forth.

 

 

FracFlow Biotechnologies LP

 

By: CHASE BANCROFT

Dated: November 13, 2014

 

Title: General Partner

 

American Xanthan Corporation

 

By: HENRY LUCE

Dated: November 13, 2014

 

Title: Chief Executive Officer